← All trials
NCT01503801
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2011
- Primary completion
- Sep 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 400
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Fudan UniversityLead sponsor
- Fudan UniversityOverall official - principal investigator
- Fudan UniversityCollaborator
- Shen-Zhen City Maternity and Child Healthcare HospitalCollaborator
- Xiamen UniversityCollaborator
- Hebei UniversityCollaborator
- Fujian Medical UniversityCollaborator
- Sun Yat-Sen UniversityCollaborator
- University of South ChinaCollaborator
- Fudan UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.